CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-10 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +45,615 | 202,100 | ||
| 2022-01-14 | HAUSMAN DIANA Director | Grant or award · Stock Option | +25,200 | $13.00 | $328K | 25,200 |
| 2021-12-22 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award | +322,691 | 329,084 | ||
| 2021-09-20 | Feinberg Peter Director | Purchase | +4,750 | $24.45 | $116K | 5,099 |
| 2021-09-13 | Feinberg Peter Director | Purchase | +5,750 | $21.51 | $124K | 392,242 |
| 2021-09-13 | Feinberg Peter Director | Purchase | +349 | $21.25 | $7K | 349 |
| 2021-09-13 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +2,083 | $22.87 | $48K | 2,602,352 |
| 2021-08-03 | Cormorant Asset Management, LP Former 10% Owner | Conversion | +1,702,628 | 1,702,628 | ||
| 2021-08-03 | Cormorant Asset Management, LP Former 10% Owner | Purchase | +550,000 | $15.00 | $8.3M | 2,252,628 |
| 2021-08-03 | Cormorant Asset Management, LP Former 10% Owner | Conversion · Series B Convertible Preferred Stock | −1,702,628 | 0 | ||
| 2021-08-03 | Feinberg Peter Director | Conversion | +133,572 | 257,325 | ||
| 2021-08-03 | Feinberg Peter Director | Purchase | +129,167 | $15.00 | $1.9M | 386,492 |
| 2021-08-03 | Feinberg Peter Director | Conversion | +123,155 | 347,401 | ||
| 2021-08-03 | Feinberg Peter Director | Purchase | +129,167 | $15.00 | $1.9M | 476,568 |
| 2021-08-03 | Feinberg Peter Director | Conversion | +82,108 | 82,108 | ||
| 2021-08-03 | Feinberg Peter Director | Purchase | +33,333 | $15.00 | $500K | 115,441 |
| 2021-08-03 | Feinberg Peter Director | Conversion · Series A Preferred Stock | −102,926 | 0 | ||
| 2021-08-03 | Feinberg Peter Director | Conversion · Series A Preferred Stock | −92,509 | 0 | ||
| 2021-08-03 | Feinberg Peter Director | Conversion · Series A Preferred Stock | −51,462 | 0 | ||
| 2021-08-03 | Feinberg Peter Director | Conversion · Series B Preferred Stock | −30,646 | 0 |
Page 10 of 12 · 226 trades